Clinical and neuropathological study of six patients with spastic paraparesis associated with HTLV-I: An axomyelinic degeneration of the central nervous system

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 4, 1997, Pages 403-413

  Cartier, Luis M ^a,c   Cea, J Gabriel ^a   Vergara, Carmen ^a   Araya, Fernando ^a   Born, Percy ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b Hospital Regional Antofagasta   (Chile)

^c Luis Thayer Ojeda   (Chile)

Author keywords

Axomyelinic degeneration; HTLV I; Neuropathology HAM TSP; Spastic paraparesis

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CENTRAL NERVOUS SYSTEM; DEMYELINATION; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; LYMPHOCYTIC INFILTRATION; NERVE DEGENERATION; NEUROPATHOLOGY; PRIORITY JOURNAL; SPASTIC PARAPLEGIA; T LYMPHOCYTE ACTIVATION;

EID: 0030693148     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199704000-00009     Document Type: Article

References (37)

1. Akizuki S, Nakazato O, Higuchi K, et al. Necropsy findings in HTLV-I myelopathy. Lancet 1987;i:156-57
2. Izumo S, Higuchi I, Ijichi T, et al. Neuropathology study in two autopsy cases of HTLV-I associated myelopathy (HAM). In neuropathology of HAM/TSP in Japan - Proceeding of the first workshop on neuropathology of retrovirus infections. Tokyo 1989:7-17
3. Kobayashi I, Ota K, Yamamoto K, et al. An autopsy case of HTLV-I associated myelopathy. Neurol Med 1989;30:409-11
4. Iwasaki Y. Pathology of chronic myelopathy associated with HTLV-I infection (HAM/TSP). J Neurol Sci 1990;96:103-23
5. Piccardo P, Ceroni M, Rodgers-Johnson P, et al. Pathological observations on tropical spastic paraparesis in patients from Jamaica. Ann Neurol 1988;23(suppl):S156-S160
6. Bhigjiee AI, While CA, Wachman W, et al. HTLV-I associated myelopathy: Clinicopathologic correlation with localization of provirus to the spinal cord. Neurology. 1991;41:1990-92
7. de Castro Costa CM, Dom R, Carton H, et al. A pathological analysis of two first Brazilian autopsied cases of HAM/TSP [abstract]. J Acquir Immune Defic Syndr Hu Ret 1995;10:229
8. Nakagawa M, Izumo S, Ijichi S, et al. HTLV-I associated myelopathy: Analysis of 213 patients based on clinical features and laboratory findings. J Neurovirology 1995;1:50-61
9. Jacobson S, Shida H, McFarlin DE, Fauci AS, Koenig S. Circulating CD8 cytotoxic T lymphocytes specific for HTLV-I associated neurological disease. Nature 1990;348:245-48
10. Iwasaki Y, Ohara Y, Kobayashi I, Akisuki S. Infiltration of helper/ inducer T lymphocytes heralds central nervous system damage in human T-cell leukemia virus infection. Am J Pathol 1992;140:1003-8
11. Umehara F, Izumo S, Nakagagua M, et al. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I associated myelopathy. J Neuropathol Exp Neurol 1993;52:424-30
12. Beham WM, Maia H. Strümpell's familiar spastic paraplegia: Genetic and neuropathology. J Neurol Neurosurg Psychiatry 1974;37:8-20
13. Umehara F, Izumo S, Ronquillo AT, et al. Cytokine expression in the spinal cord lesions in HTLV-I associated myelopathy. J Neuropath Exp Neurol 1994;53:72-77
14. Moore GRW, Traugott U, Scheimberg LC, Raine CS. Tropical spastic paraparesis: A model of virus-induced, cytotoxic T-cell-mediated demyelination? Ann Neurol 1989;26:523-30
15. Jacobson S, Zaninovic V, Mora C, et al. Immunological findings in neurological diseases associated with antibodies to HTLV-I: Activated lymphocytes in tropical spastic paraparesis. Ann Neurol 1988;23:S196-S200
16. Powell HC, Lampert PW. Pathology of multiple sclerosis. Neurologic Clinics Vol 1 N3. 1983:631-53
17. Richardson EP. Progressive multifocal leukoencephalopathy. In: PJ Vinken, Bruyn GW, eds. Handbook of clinical neurology. Multiple sclerosis and other demyelinating disease. Amsterdam: North-Holland Publ. Co., 1979:485-99
18. Raine CS. Oligodendrocytes and central nervous system myelin. Textbook of neuropathology. 1991:115-40
19. Brodai A. Neurological anatomy: In relation to clinical medicine. The somatic afferent pathways. Oxford University Press Inc. 1981: 74-84
20. Gore M, Thakare J, Ghosh S, Wadia R. Retrovirus mediated myelopathies are these autoimmune disorders induced by altered antigens. Arch Neurol 1988;45:601-2
21. Parker CE, Daenke S, Nightingale S, Bangham CR. Activated HTLV-I specific cytotoxic T-lymphocytes are found in healthy seropositives as well as in patients with tropical spastic paraparesis. Virology 1992;188:528-636
22. Galeno H, Ramirez E, Cartier L. HTLV-I provirus in seronegative Chilean patients with tropical spastic paraparesis. Lancet 1996;348:1170
23. Yoshiki T. Chronic progressive myeloneuropathy in WKAH rats induced by HTLV-I infection as an animal model for HAM/TSP in humans. Intervirology 1995;38:229-37
24. Itoyama Y, Minato S, Goto I, et al. Spontaneous proliferation of peripheral blood lymphocytes increased in patients with HTLV-I associated myelopathy. Neurology 1988;38:1302-7
25. Eiraku N, Ijichi S, Yashiki, et al. Cell surface phenotype of in vitro proliferating lymphocytes in HTLV-I associated myelopathy (HAM/TSP). J Neuroimmunol 1992;37:223-28
26. Osame M, Matsumoto M, Usuku K, et al. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotrophic virus type I and adult T-cell leukemia-like cell. Ann Neurol 1987;21:117-21
27. Cartier L, Araya F, Castillo JL, et al. Progressive spastic paraparesis associated with human T cell leukemia virus type I (HTLV-I). Intern Med 1992;31:1257-61
28. Giraudon P, Bernard A, Malcus C, et al. Retroviral infection (HTLV-I) induces cytokines-regulated immunomodulation and cytotoxicity of medulloblastoma cells. J Neuropath Exp Neurol 1995;54:165-74
29. Giraudon P, Thomasset N, Bernard A, et al. Induction of MMP9 (92 kDA Gelatinase) activity and expression of tissue inhibitor of metalloproteinase-2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-I. Eur J Neurosci 1995;7:841-48
30. Ogata A, Nagashima K, Tashiro K, Miyakawa A, Mikuni C. MRI-pathological correlate of brain lesions in a necropsy case of HTLV-I associated myelopathy. J Neurol Neurosurg Psychiatry 1993;56:194-96
31. Smith C, Dixon D, Samkoff L. Recurrent encephalopathy and seizures in US native with HTLV-I associated myelopathy/tropical spastic paraparesis: A clinicopathological study. Neurology 1992;42:658-61
32. Kira J, Fujibara K, Itoyawa Y, et al. Leukoencephalopathy in HTLV-I associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year study follow up study after corticosteroids therapy. J Neurol Sciences 1991;106:41-49
33. Cartier L, Castillo JL, Cea JG, Villagra R. Chronic dacryosialadenitis in HTLV-I associated myelopathy. J Neurol Neurosurg Psychiatry 1995;58:244-46
34. Cartier L, Castillo JL, Cabrera ME, et al. HTLV-I positive spastic paraparesis (TSP) associated with a lymphoid disorder in three Chilean patients. Leukemia Lymphoma 1995;17:459-54
35. Kitajima I, Naruyama I, Naruyama Y. Polyarthritis in human T lymphocytes virus type I associated myelopathy. Arthritis Rheum 1989;32:1342-44
36. Sugimoto M, Nakashima H, Watanake S, et al. T-lymphocytes alveolitis in HTLV-I associated myelopathy. Lancet 1987;ii:1220
37. Navarro-Roman L, Corbin DO, Katz D, et al. Human T lymphotropic virus type I DNA in the spinal cord of tropical spastic paraparesis with concomitant human T lymphotropic virus type I negative Hodgkin's disease. Human Pathol 1994;25:1101-6